Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieran F Docherty

Showing results (51-60 of 174) with videos related to

Pageof 18
Sort By:
European Journal of Heart Failure|March 2, 2026
Do we need exercise echocardiography to diagnose HFpEF? Not at allAlice Brennan, Ross T Campbell, Kieran F Docherty, et al.
European Journal of Heart Failure|February 24, 2022
Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rateJawad H Butt, Carly Adamson, Kieran F Docherty, et al.
European Heart Journal. Acute Cardiovascular Care|April 28, 2025
The intersection of obesity and acute heart failure: Cardiac structure and function and congestion across BMI categoriesSofie Bøgh-Sørensen, Ross T Campbell, Brian L Claggett, et al.
European Journal of Heart Failure|September 26, 2022
Health-related quality of life in acute heart failure: association between patient-reported symptoms and markers of congestionMatthew M Y Lee, Ross T Campbell, Brian L Claggett, et al.
JACC. Heart Failure|September 13, 2024
Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy: A Meta-Analysis of DAPA-HF and DELIVERJawad H Butt, Li Shen, Silvio E Inzucchi, et al.
JACC. Heart Failure|October 11, 2020
Estimating the Lifetime Benefits of Treatments for Heart FailureJoão Pedro Ferreira, Kieran F Docherty, Susan Stienen, et al.
British Journal of Clinical Pharmacology|May 20, 2026
External validation of the BAN-ADHF diuretic-resistance score in the DAPA-RESIST clinical trialDominic M Alfonso, Kieran F Docherty, Matthew M Y Lee, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 18, 2020
Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysisMatthew M Y Lee, Kieran F Docherty, Naveed Sattar, et al.
European Heart Journal|March 6, 2025
Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysisMatthew Ryan, Mark C Petrie, Evangelos Kontopantelis, et al.
ESC Heart Failure|December 11, 2020
Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodellingKieran F Docherty, Ross T Campbell, Katriona J M Brooksbank, et al.
Pageof 18

Showing results (51-60 of 174) with videos related to

Sort By:
Pageof 18
European Journal of Heart Failure|March 2, 2026
Do we need exercise echocardiography to diagnose HFpEF? Not at allAlice Brennan, Ross T Campbell, Kieran F Docherty, et al.
European Journal of Heart Failure|February 24, 2022
Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rateJawad H Butt, Carly Adamson, Kieran F Docherty, et al.
European Heart Journal. Acute Cardiovascular Care|April 28, 2025
The intersection of obesity and acute heart failure: Cardiac structure and function and congestion across BMI categoriesSofie Bøgh-Sørensen, Ross T Campbell, Brian L Claggett, et al.
European Journal of Heart Failure|September 26, 2022
Health-related quality of life in acute heart failure: association between patient-reported symptoms and markers of congestionMatthew M Y Lee, Ross T Campbell, Brian L Claggett, et al.
JACC. Heart Failure|September 13, 2024
Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy: A Meta-Analysis of DAPA-HF and DELIVERJawad H Butt, Li Shen, Silvio E Inzucchi, et al.
JACC. Heart Failure|October 11, 2020
Estimating the Lifetime Benefits of Treatments for Heart FailureJoão Pedro Ferreira, Kieran F Docherty, Susan Stienen, et al.
British Journal of Clinical Pharmacology|May 20, 2026
External validation of the BAN-ADHF diuretic-resistance score in the DAPA-RESIST clinical trialDominic M Alfonso, Kieran F Docherty, Matthew M Y Lee, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 18, 2020
Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysisMatthew M Y Lee, Kieran F Docherty, Naveed Sattar, et al.
European Heart Journal|March 6, 2025
Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysisMatthew Ryan, Mark C Petrie, Evangelos Kontopantelis, et al.
ESC Heart Failure|December 11, 2020
Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodellingKieran F Docherty, Ross T Campbell, Katriona J M Brooksbank, et al.
Pageof 18